Autoradiographic mapping of μ-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 362, Issue 2, 2000, Pages 101-109

  Diaz, A ^a   Pazos, A ^a   Florez, J ^a   Hurle, M A ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Autoradiography; Nimodipine; Opioid receptor; Opioid tolerance; Sufentanil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NIMODIPINE; OPIATE AGONIST; OPIATE RECEPTOR; SUFENTANIL; TRITIUM;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; DRUG TOLERANCE; LIGAND BINDING; MALE; NEUROPHARMACOLOGY; NONHUMAN; RAT; RECEPTOR DENSITY; SPINAL CORD;

ANALGESICS, OPIOID; ANIMALS; AUTORADIOGRAPHY; BRAIN MAPPING; CALCIUM CHANNEL BLOCKERS; CENTRAL NERVOUS SYSTEM; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; LIGANDS; MALE; NARCOTICS; NIMODIPINE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SUFENTANIL;

EID: 0033874470     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000258     Document Type: Article

References (49)

1. Effect of clonidine, nimodipine and diltiazem on the in vitro opioid withdrawal response in the guinea-pig ileum
2. Cortical dihydropyridine binding sites and behavioral syndrome in morphine-abstinent rats
3. Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine
4. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats
5. The potent opiate agonist, (+)-cis-3-methylfentanyl binds pseudoirreversibly to the opioid receptor complex in vitro and in vivo: Evidence for a novel mechanism of action
6. Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro
7. μ-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance
8. Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats
9. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats
10. Fentanyl and its analogs sensitize the cloned mu opioid receptor
11. Effect of nimodipine, diltiazem and Bay K 8644 on the behavioral and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine
12. Opioid receptor-G protein interactions: Acute and chronic effects of opioids
13. 2+ channels during opioid tolerance and supersensitivity in rats
14. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system
15. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system
16. Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions
17. In vivo opiate binding unchanged in tolerant/dependent mice
18. Multiple opioid receptors: Ligand selectivity profiles and binding site signatures
19. Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-μ-receptor agonists and neuropharmacological actions in rodents
20. Acute systemic administration of morphine selectivity increases mu opioid receptor binding in the rat brain
21. Down-regulation of 3H-lofentanil binding to opiate receptors in different neuronal cells
22. Anatomical distribution of opioid receptors in mammalians: An overview
23. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat
24. Antagonist-induced opioid receptor up-regulation. I. Characterisation of supersensitivity to selective Mu and Kappa agonists
25. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of Mu, Delta and Kappa binding sites in rat brain revealed by quantitative autoradiography
26. Under siege: The brain on opiates
27. Dissociation of mu opioid tolerance from down-regulation in rat spinal cord
28. Agonist-induced functional desensitization of the opioid receptor is mediated by loss of membrane receptor rather than uncoupling from G protein
29. 3H-noradrenaline release
30. Chronic administration of morphine and naltrexone up-regulate opioid binding sites labelled by 3H-[D-ala2-MePhe4,Gly-ol5]enkephalin: Evidence for two mu binding sites
31. The calcium channel agonist Bay K 8644 induces central respiratory depression in cats, an effect blocked by naloxone
32. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine. A preliminary report
33. Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: A double-blind placebo-controlled study
34. Complexity and diversity of mammalian adenylyl-cyclases
35. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment
36. Decrease in μ-opioid receptor binding capacity in rat brain after chronic PL017 treatment
37. Molecular basis of drug action
38. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation
39. Morphine-induced downregulation of μ-opioid receptors in neonatal rat brain
40. Calciumantagonisten in der Anaesthesie: Additive Analgesie durch Nimodipin wahrend cardiochirurgischer Eingriffe
41. Chronic opioid antagonist treatment: Assessment of receptor upregulation
42. Simultaneous development of opioid tolerance and opioid antagonist-induced upregulation
43. Opioid receptor regulation in mice
44. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y neuroblastoma cells
45. Role of G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness
46. Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats
47. Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment
48. Opioid receptor regulation